SCHEMBL4247291

SCHEMBL4247291

CC(C)OC(=O)c1cc(=O)c2cccc(N)c2o1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.56
NR3C2 P08235 3/20 0.47
GPR35 Q9HC97 6/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
MAOB P27338 1/20 0.43
KDM4E B2RXH2 5/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
ALDH1A1 P00352 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4251645 0.86 KDM4E (0.53) GPR35GAAMAPTMAOBKDM4E
SCHEMBL4252013 0.83 MAOB (0.49) AKR1B1GPR35GAAMAPTMAOB
SCHEMBL4254725 0.83 AKR1B1 (0.57) AKR1B1GPR35GAAMAPTMAOB
SCHEMBL4249060 0.83 GPR35 (0.42) AKR1B1GPR35GAAMAPTMAOB
SCHEMBL4254657 0.81 AKR1B1 (0.56) AKR1B1GPR35GAAMAPTMAOB
SCHEMBL4250588 0.81 MAOB (0.69) AKR1B1GPR35MAPTMAOBKDM4E
SCHEMBL29393797 0.80 AKR1B1 (0.70) AKR1B1GAAMAPTMAOBKDM4E
SCHEMBL28290283 0.80 GPR35 (0.47) GPR35KDM4EKMT2AALDH1A1USP2
SCHEMBL4253451 0.80 GPR35 (0.61) AKR1B1GPR35KDM4EALDH1A1USP2
SCHEMBL4250424 0.80 GPR35 (0.69) AKR1B1NR3C2GPR35GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101497571-B Process for producing chromone compound SUMITOMO CO LTD 2012-07-04 CN disclosed
CN-1911896-B Process for producing benzopyrone compound SUMITOMO CHEMICAL CO 2010-09-15 CN disclosed
EP-2105431-A1 Process for Producing Chromone Compound Sumitomo Chemical Company, Limited (JP) 2009-09-30 EP disclosed
EP-2105432-A1 Process for Producing Chromone Compound Sumitomo Chemical Company, Limited (JP) 2009-09-30 EP disclosed
CN-101497571-A Process for producing chromone compound SUMITOMO CHEMICAL CO (JP) 2009-08-05 CN disclosed
CN-100509751-C Process for producing benzopyranone compound SUMITOMO CHEMICAL CO (JP) 2009-07-08 CN disclosed
EP-1867626-A2 Process for producing chromone compound Sumitomo Chemical Company, Limited (JP) 2007-12-19 EP disclosed
CN-1911896-A Process for producing chromone compound SUMITOMO CHEMICAL CO (JP) 2007-02-14 CN disclosed
US-20060217565-A1 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-09-28 US disclosed
US-7094914-B2 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-08-22 US disclosed
CN-1649824-A Process for producing benzopyranone compound SUMITOMO CHEMICAL CO (JP) 2005-08-03 CN disclosed
US-20050085664-A1 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LMITED (JP) 2005-04-21 US disclosed
EP-1479667-A1 PROCESS FOR PRODUCING CHROMONE COMPOUND Sumitomo Chemical Company, Limited (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050085664-A1 Process for producing chromone compound ENY2, CDY1; CDY1B, CDYL AKR1B1 237/4885NR3C2 68/4885GPR35 2693/4885
US-20060217565-A1 Process for producing chromone compound ENY2, CDY1; CDY1B, CDYL AKR1B1 237/4885NR3C2 68/4885GPR35 2693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.